Abstract:Macrophages, exhibiting high intrinsic accumulation and infiltration into tumor tissues, are a novel drug vehicle for directional drug delivery. However, the low drug-loading (DL) capacity and the drug cytotoxicity to the cell vehicle have limited the application of macrophages in tumor therapy. In this study, different drugs involving small molecular and nanoparticle drugs were loaded into intrinsic macrophages to find a better way to overcome these limitations. Their DL capacity and cytotoxicity to the macrophages were first compared. Furthermore, their phagocytic ratio, dynamic distributions, and tumoricidal effects were also investigated. Results indicated that more lipid-soluble molecules and DL particles can be phagocytized by macrophages than hydrophilic ones. In addition, the N-succinyl-N′-octyl chitosan (SOC) DL particles showed low cytotoxicity to the macrophage itself, while the dynamic biodistribution of macrophages engulfed with different particles/small molecules showed similar profiles, mainly excreted from liver to intestine pathway. Furthermore, macrophages loaded with SOC–paclitaxel (PTX) particles exhibited greater therapeutic efficacies than those of macrophages directly carrying small molecular drugs such as doxorubicin and PTX. Interestingly, macrophages displayed stronger targeting ability to the tumor site hypersecreting chemokine in immunocompetent mice in comparison to the tumor site secreting low levels of chemokine in immunodeficiency mice. Finally, results demonstrated that macrophages carrying SOC–PTX are a promising pharmaceutical preparation for tumor-targeted therapy.

Role of macrophage in nanomedicine-based disease treatment

Use of macrophage as a Trojan horse for cancer nanotheranostics

Advances in Macrophage-Targeting Nanoparticles for the Diagnosis and Treatment of Inflammatory Bowel Disease.

Engineering Macrophages <i>via</i> Nanotechnology and Genetic Manipulation for Cancer Therapy

The promising role of tumor-associated macrophages in the treatment of cancer

Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Macrophage: Hidden Criminal in Therapy Resistance.

Current Development of Nano-Drug Delivery to Target Macrophages

Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.

How to use macrophages to realise the treatment of tumour

Engineering macrophages and their derivatives: A new hope for antitumor therapy

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Macrophage-modulating nanomedicine for cancer immunotherapy

Nanomedicine engulfed by macrophages for targeted tumor therapy

New insights into the role of macrophages in cancer immunotherapy

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer

Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders

Active Nano-targeting of Macrophages

Leveraging macrophages for cancer theranostics